BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

697 related articles for article (PubMed ID: 23389848)

  • 41. The microRNA miR-139 suppresses metastasis and progression of hepatocellular carcinoma by down-regulating Rho-kinase 2.
    Wong CC; Wong CM; Tung EK; Au SL; Lee JM; Poon RT; Man K; Ng IO
    Gastroenterology; 2011 Jan; 140(1):322-31. PubMed ID: 20951699
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Down-regulation of miR-26a-5p in hepatocellular carcinoma: A qRT-PCR and bioinformatics study.
    Liang L; Zeng JH; Wang JY; He RQ; Ma J; Chen G; Cai XY; Hu XH
    Pathol Res Pract; 2017 Dec; 213(12):1494-1509. PubMed ID: 29113686
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tumor-associated macrophage promotes tumor progression via STAT3 signaling in hepatocellular carcinoma.
    Mano Y; Aishima S; Fujita N; Tanaka Y; Kubo Y; Motomura T; Taketomi A; Shirabe K; Maehara Y; Oda Y
    Pathobiology; 2013; 80(3):146-54. PubMed ID: 23364389
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity.
    Su H; Yang JR; Xu T; Huang J; Xu L; Yuan Y; Zhuang SM
    Cancer Res; 2009 Feb; 69(3):1135-42. PubMed ID: 19155302
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.
    Xia H; Ooi LL; Hui KM
    Hepatology; 2013 Aug; 58(2):629-41. PubMed ID: 23471579
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MicroRNA-331-3p promotes proliferation and metastasis of hepatocellular carcinoma by targeting PH domain and leucine-rich repeat protein phosphatase.
    Chang RM; Yang H; Fang F; Xu JF; Yang LY
    Hepatology; 2014 Oct; 60(4):1251-63. PubMed ID: 24825302
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Honokiol inhibits signal transducer and activator of transcription-3 signaling, proliferation, and survival of hepatocellular carcinoma cells via the protein tyrosine phosphatase SHP-1.
    Rajendran P; Li F; Shanmugam MK; Vali S; Abbasi T; Kapoor S; Ahn KS; Kumar AP; Sethi G
    J Cell Physiol; 2012 May; 227(5):2184-95. PubMed ID: 21792937
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gankyrin promotes tumor growth and metastasis through activation of IL-6/STAT3 signaling in human cholangiocarcinoma.
    Zheng T; Hong X; Wang J; Pei T; Liang Y; Yin D; Song R; Song X; Lu Z; Qi S; Liu J; Sun B; Xie C; Pan S; Li Y; Luo X; Li S; Fang X; Bhatta N; Jiang H; Liu L
    Hepatology; 2014 Mar; 59(3):935-46. PubMed ID: 24037855
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic significance of AMPK activation and therapeutic effects of metformin in hepatocellular carcinoma.
    Zheng L; Yang W; Wu F; Wang C; Yu L; Tang L; Qiu B; Li Y; Guo L; Wu M; Feng G; Zou D; Wang H
    Clin Cancer Res; 2013 Oct; 19(19):5372-80. PubMed ID: 23942093
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MicroRNA-340 inhibits the proliferation and invasion of hepatocellular carcinoma cells by targeting JAK1.
    Yuan J; Ji H; Xiao F; Lin Z; Zhao X; Wang Z; Zhao J; Lu J
    Biochem Biophys Res Commun; 2017 Jan; 483(1):578-584. PubMed ID: 27998770
    [TBL] [Abstract][Full Text] [Related]  

  • 51. DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation.
    Lai SC; Su YT; Chi CC; Kuo YC; Lee KF; Wu YC; Lan PC; Yang MH; Chang TS; Huang YH
    J Exp Clin Cancer Res; 2019 Nov; 38(1):474. PubMed ID: 31771617
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway.
    Zhao H; Guo Y; Li S; Han R; Ying J; Zhu H; Wang Y; Yin L; Han Y; Sun L; Wang Z; Lin Q; Bi X; Jiao Y; Jia H; Zhao J; Huang Z; Li Z; Zhou J; Song W; Meng K; Cai J
    Oncotarget; 2015 Oct; 6(31):31927-43. PubMed ID: 26376676
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MicroRNA-125b promotes apoptosis by regulating the expression of Mcl-1, Bcl-w and IL-6R.
    Gong J; Zhang JP; Li B; Zeng C; You K; Chen MX; Yuan Y; Zhuang SM
    Oncogene; 2013 Jun; 32(25):3071-9. PubMed ID: 22824797
    [TBL] [Abstract][Full Text] [Related]  

  • 54. miR-383 inhibits cell growth and promotes cell apoptosis in hepatocellular carcinoma by targeting IL-17 via STAT3 signaling pathway.
    Wang J; Lu L; Luo Z; Li W; Lu Y; Tang Q; Pu J
    Biomed Pharmacother; 2019 Dec; 120():109551. PubMed ID: 31648164
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma.
    Zhou SL; Dai Z; Zhou ZJ; Wang XY; Yang GH; Wang Z; Huang XW; Fan J; Zhou J
    Hepatology; 2012 Dec; 56(6):2242-54. PubMed ID: 22711685
    [TBL] [Abstract][Full Text] [Related]  

  • 56. microRNA-539 suppresses tumor growth and tumorigenesis and overcomes arsenic trioxide resistance in hepatocellular carcinoma.
    Zhu C; Zhou R; Zhou Q; Chang Y; Jiang M
    Life Sci; 2016 Dec; 166():34-40. PubMed ID: 27717846
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A novel obatoclax derivative, SC-2001, induces apoptosis in hepatocellular carcinoma cells through SHP-1-dependent STAT3 inactivation.
    Chen KF; Su JC; Liu CY; Huang JW; Chen KC; Chen WL; Tai WT; Shiau CW
    Cancer Lett; 2012 Aug; 321(1):27-35. PubMed ID: 22465052
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MicroRNA-26a promotes anoikis in human hepatocellular carcinoma cells by targeting alpha5 integrin.
    Zhang X; Cheng SL; Bian K; Wang L; Zhang X; Yan B; Jia LT; Zhao J; Gammoh N; Yang AG; Zhang R
    Oncotarget; 2015 Feb; 6(4):2277-89. PubMed ID: 25537511
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Underexpressed microRNA-199b-5p targets hypoxia-inducible factor-1α in hepatocellular carcinoma and predicts prognosis of hepatocellular carcinoma patients.
    Wang C; Song B; Song W; Liu J; Sun A; Wu D; Yu H; Lian J; Chen L; Han J
    J Gastroenterol Hepatol; 2011 Nov; 26(11):1630-7. PubMed ID: 21557766
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Thirty-kilodalton Tat-interacting protein suppresses tumor metastasis by inhibition of osteopontin transcription in human hepatocellular carcinoma.
    Zhao J; Lu B; Xu H; Tong X; Wu G; Zhang X; Liang A; Cong W; Dai J; Wang H; Wu M; Guo Y
    Hepatology; 2008 Jul; 48(1):265-75. PubMed ID: 18537194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.